Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genzyme Rejects Sanofi's $18.5B Offer
TheStreet.com
Monday, August 30, 2010 - 10:04am
tags:
Genzyme, Sanofi, M&A
Sanofi Goes Public With Genzyme Offer for First Time .
WSJ
Sunday, August 29, 2010 - 1:10pm
tags:
Sanofi, Genzyme, M&A
Big Pharma: Why In-Licensing Is Not the Cure
SeekingAlpha
Sunday, August 29, 2010 - 1:07pm
tags:
Big Pharma
Lupin looks to cash in on WHO pre-qualification of TB drug
Business Standard, India
Sunday, August 29, 2010 - 1:05pm
tags:
Lupin, tuberculosis, ethambutol
Average Paxil Birth Defect Settlement $1.2 Million
lawyersandsettlements.com
Sunday, August 29, 2010 - 12:38pm
tags:
Paxil, GSK
Fosun Pharma Acquires $14 Million of Chindex International, Inc.
Pipeline Review
Sunday, August 29, 2010 - 12:17pm
tags:
Chindex, Fosun Pharmaceutical
Big pharma kisses its blockbuster years goodbye
The Independent, UK
Sunday, August 29, 2010 - 12:06pm
tags:
Big Pharma
AstraZeneca pension row sparks merger speculation
Pharmatimes
Sunday, August 29, 2010 - 11:54am
tags:
AstraZeneca, M&A
Why I Bought ImmunoGen After the Plunge
SeekingAlpha
Sunday, August 29, 2010 - 11:37am
tags:
Immunogen
J&J recalls 2 hip replacement systems for problems
Yahoo/AP
Sunday, August 29, 2010 - 11:34am
tags:
JNJ
Dividend Report Card: Johnson & Johnson
Motley Fool
Sunday, August 29, 2010 - 11:32am
tags:
JNJ
Genzyme shortages ease
bizjournals.com
Saturday, August 28, 2010 - 8:47am
tags:
Genzyme, Cerezyme, Gaucher disease, Fabrazyme, Fabry's disease
AstraZeneca's Dividends May Not Last Forever
Motley Fool
Saturday, August 28, 2010 - 8:45am
tags:
AstraZeneca, investors
CEO: J&J let down public, must work to build trust
Yahoo/AP
Saturday, August 28, 2010 - 8:44am
tags:
JNJ, recalls
Down 35%! This Just Shouldn't Happen (ImmunoGen)
Motley Fool
Saturday, August 28, 2010 - 8:42am
tags:
Immunogen, GSK, Sanofi, Biogen Idec
Endo Pharmaceuticals Looks For Acquisitions
Yahoo/Investor's Business Daily
Saturday, August 28, 2010 - 8:39am
tags:
Endo
Lilly wins longer halt of generic Strattera sales
Reuters
Friday, August 27, 2010 - 11:32am
tags:
Eli Lilly, generics, Strattera, ADHD, Mylan, Teva Pharmaceuticals
ImmunoGen sinks as drug sector indexes rise
Marketwatch
Friday, August 27, 2010 - 11:16am
tags:
Immunogen, drug stocks
Vanda's Pipeline Progresses
Yahoo/Zacks.com
Friday, August 27, 2010 - 11:11am
tags:
Vanda, tasimelteon
Arena Pharma: Using Options to Trade on FDA's Decision for Key Obesity Drug
Seeking Alpha
Friday, August 27, 2010 - 11:10am
tags:
Arena Pharmaceuticals, obesity, FDA, Vivus, Orexigen, Contrave, Qnexa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.